260 likes | 451 Views
Taming the Devil Inside: Pharmacologic Management of Hypertension. Christopher Roe, MSN, ACNP-BC Lead Nurse Practitioner Christiana Care Cardiology Consultants. Why Bother?. 78 million adults have HTN Directly linked to myocardial infarction, stroke, heart failure, and kidney disease
E N D
Taming the Devil Inside:Pharmacologic Management of Hypertension Christopher Roe, MSN, ACNP-BC Lead Nurse Practitioner Christiana Care Cardiology Consultants
Why Bother? • 78 million adults have HTN • Directly linked to myocardial infarction, stroke, heart failure, and kidney disease • Estimated cost $51 billion in 2009 Statistics from:http://www.heart.org/idc/groups/heart-public/@wcm/@sop/@smd/documents/downloadable/ucm_319587.pdf
Who is the Devil? • Hormonal Mechanisms • Neural Mechanisms • Vascular Mechanisms • Renal Mechanisms
What is the definition? EHA/ESC Guidelines JNC-7 Guidelines
Treatment of Stage or Grade 1 HTN (without compelling indications) • JNC-7 • Thiazide Diuretic • May consider ACEi, ARB, BB, CCB, or combo • ESH/ESC • Your choice: no agent is superior • Thiazide Diuretic, BB, CCB, ACEi, or ARB
Thiazide Diuretics • Hydrochlorothiazide • Chlorthalidone • Indapamide (“thiazide-like”) • Mechanism of Action—diuresis & vasodilation • Side Effects • Disease related issues
Angiotensin Converting Enzyme Inhibitors (ACEi) captopril, lisinopril, ramipril, enalapril, trandopril, benazepril Mechanism of Action
Angiotensin Converting Enzyme Inhibitors (ACEi) • Side Effects • Cough • Angioedema • Hyperkalemia • Elevated BUN/Cr • Disease Related issues
Angiotensin Receptor Blockers • valsartan, losartan, telmisartan, candesartan • Mechanism of Action • Side Effects • Disease related issues
Calcium Channel Blockers Dihydropyridine Non-dihydropyridine
Calcium Channel BlockersDihydropyridine • amlodipine, felodipine, nicardipine, nifedipine • Mechanism of Action • Side Effects • Disease related issues
Calcium Channel BlockersNon-dihydropyridine • diltiazem and verapamil • Mechanism of Action • Side Effects • Disease Related Issues
Beta Blocker • atenolol, propranolol, metoprolol, nadolol • Subtypes of Beta Recptors • β-1 • β-2 • Mechanism of Action • Subgroupings of Beta Blockers • Nonselective • Selective • Nonselective with alpha-1 blocking
Beta Blocker • Side Effects • Disease Related Issues
Other Antihypertensives • Aldosterone Antagonists • Central Acting Alpha-2 Agonists (presynaptic) • Alpha-1 Adrenergic Antagonists (postsynaptic) • Direct Vasodilators • Renin Inhibitors • Others
Novel Pharmacologic Therapies • Vitamin D • Fish Oil • Statins • Aspirin
Not So Novel Non-Pharmacologic Agents Reduce Salt Intake Reduce Alcohol Intake Increase Aerobic Activity
Novel Interventional Techniques Renal Nerve Denervation